163 related articles for article (PubMed ID: 23494468)
21. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
[TBL] [Abstract][Full Text] [Related]
22. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
23. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride.
Toti US; Aminabhavi TM
J Control Release; 2004 Mar; 95(3):567-77. PubMed ID: 15023467
[TBL] [Abstract][Full Text] [Related]
24. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
[TBL] [Abstract][Full Text] [Related]
25. Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.
Choudhary H; Agrawal AK; Malviya R; Yadav SK; Jaliwala YA; Patil UK
Pharmazie; 2010 Mar; 65(3):194-8. PubMed ID: 20383939
[TBL] [Abstract][Full Text] [Related]
26. Novel levodopa formulations in the treatment of Parkinson's disease.
Pilleri M; Antonini A
Expert Rev Neurother; 2014 Feb; 14(2):143-9. PubMed ID: 24428803
[TBL] [Abstract][Full Text] [Related]
27. DEVELOPMENT OF COMPRESSED COATED POLYPILL WITH MUCOADHESIVE CORE COMPRISING OF ATORVASTATIN/CLOPIDOGREL/ASPIRIN USING COMPRESSION COATING TECHNIQUE.
Shahid N; Adnan S; Farooq M; Ali S; Shabbir M; Masood Z; Waqar K; Saleem H; Gill SA; Ali T
Acta Pol Pharm; 2017 Mar; 74(2):477-487. PubMed ID: 29624252
[TBL] [Abstract][Full Text] [Related]
28. Novel Levodopa Formulations for Parkinson's Disease.
Freitas ME; Ruiz-Lopez M; Fox SH
CNS Drugs; 2016 Nov; 30(11):1079-1095. PubMed ID: 27743318
[TBL] [Abstract][Full Text] [Related]
29. Microwave initiated synthesis of polyacrylamide grafted guar gum (GG-g-PAM)-Characterizations and application as matrix for controlled release of 5-amino salicylic acid.
Sen G; Mishra S; Jha U; Pal S
Int J Biol Macromol; 2010 Aug; 47(2):164-70. PubMed ID: 20471416
[TBL] [Abstract][Full Text] [Related]
30. Effect of carboxymethylcellulose and locust bean gums on some of physicochemical, mechanical, and textural properties of extruded rice.
Mirzaei M; Movahhed S; Asadollahzadeh MJ; Ahmadi Chenarbon H
J Texture Stud; 2021 Feb; 52(1):91-100. PubMed ID: 32978793
[TBL] [Abstract][Full Text] [Related]
31. Optimization of budesonide compression-coated tablets for colonic delivery.
Yehia SA; Elshafeey AH; Sayed I; Shehata AH
AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
33. Formulation of novel chitosan guargum based hydrogels for sustained drug release of paracetamol.
Sami AJ; Khalid M; Jamil T; Aftab S; Mangat SA; Shakoori AR; Iqbal S
Int J Biol Macromol; 2018 Mar; 108():324-332. PubMed ID: 29217184
[TBL] [Abstract][Full Text] [Related]
34. Psyllium and copolymers of 2-hydroxylethylmethacrylate and acrylamide-based novel devices for the use in colon specific antibiotic drug delivery.
Singh B; Chauhan N; Kumar S; Bala R
Int J Pharm; 2008 Mar; 352(1-2):74-80. PubMed ID: 18055144
[TBL] [Abstract][Full Text] [Related]
35. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
36. Statistical optimisation of the mucoadhesivity and characterisation of multipolymeric propranolol matrices for buccal therapy.
Munasur AP; Pillay V; Chetty DJ; Govender T
Int J Pharm; 2006 Oct; 323(1-2):43-51. PubMed ID: 16863686
[TBL] [Abstract][Full Text] [Related]
37. ASSESSMENT OF GUAR AND XANTHAN GUM BASED FLOATING DRUG DELIVERY SYSTEM CONTAINING MEFENAMIC ACID.
Khan KAUR; Naeem M; Ali A; Rehman NU; Nawaz Z; Akram MR; Khan JA
Acta Pol Pharm; 2016 Sep; 73(5):1287-1297. PubMed ID: 29638069
[TBL] [Abstract][Full Text] [Related]
38. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
39. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
Abdelkader H; Abdalla OY; Salem H
AAPS PharmSciTech; 2007 Nov; 8(4):E100. PubMed ID: 18181521
[TBL] [Abstract][Full Text] [Related]
40. Guar gum as platform for the oral controlled release of therapeutics.
Aminabhavi TM; Nadagouda MN; Joshi SD; More UA
Expert Opin Drug Deliv; 2014 May; 11(5):753-66. PubMed ID: 24650099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
